Led by Legend Capital, Easy-Flow Raises Tens of Millions of CNY in Angel Round
Nov 01, 2022 17:51 HKT |  |
|
Inaugural International Healthcare Week promotes Hong Kong as leading healthcare hub
Oct 31, 2022 19:00 HKT |  |
|
Zhaoke Ophthalmology's Partner Vyluma Announces Positive Results from Phase III CHAMP Study of NVK002 for Treatment of Myopia Progression in Children
Oct 28, 2022 09:45 HKT |  |
|
Malaysian Genomics Signs Strategic Collaboration Agreement for Expansion in the UAE
Oct 26, 2022 19:00 HKT |  |
|
Clinical Research Opportunities in China and the Path to USFDA Approval - Whitepaper
Oct 25, 2022 18:00 HKT |  |
|
Olympus Announces Leadership Succession Plan
Oct 21, 2022 14:00 HKT |  |
|
Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round
Oct 20, 2022 14:45 HKT | |
|
Sirnaomics to Present Latest Developments on GalAhead(TM) Therapeutic Platform at Upcoming Industry Conferences
Oct 19, 2022 13:01 HKT | |
|
AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program
Oct 18, 2022 07:00 HKT |  |
|
The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval
Oct 17, 2022 11:00 HKT | |
|
EC Healthcare expects a record-high semi-annual sales volume in first half of FY23 of no less than HK$1.8 billion, Represents no less than 17% Y-o-Y increase
Oct 17, 2022 08:48 HKT |  |
|
Essex Biotechnology Secures Exclusive Rights and Interests in SkQ1 for Ophthalmology from Mitotech
Oct 13, 2022 22:40 HKT |  |
|
Malaysian Genomics Signs Agreement with National Institutes of Health to Explore Research Opportunities
Oct 12, 2022 13:00 HKT | |
|
Novotech India Recognised as "Best Workplaces for Women 2022" by Global Work Standards Authority
Oct 12, 2022 09:00 HKT | |
|
ClinicalSquared Partners with Solve.Care to Create Web3 Health Networks on the Blockchain
Oct 11, 2022 07:20 HKT |  |
|
Olympus EU-ME3 Ultrasound Processor, Delivers Higher Resolution Images for Endoscopic Ultrasound
Oct 10, 2022 14:00 HKT | |
|
Hua Medicine's Innovative First-In-Class Glucokinase Activator (GKA) HuaTangNing Is Approved, New Type 2 Diabetes Treatment Paradigm to Begin in China
Oct 10, 2022 09:00 HKT | |
|
Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO
Oct 07, 2022 10:00 HKT | |
|
AIM Vaccine, a Major Player in the Chinese Vaccine Industry, Successfully Listed on the Main Board of SEHK
Oct 06, 2022 19:16 HKT |  |
|
AIM Vaccine Announces Global Offering Results, Offer Price of HK$16.16 per H Share
Oct 05, 2022 18:55 HKT | |
|